PPT-MM: HCV and Cirrhosis Patient Case

Chris Kolkman PrimaryOne Health Meet MM Patient Background MM is a 59yearold Hispanic female who presents for a regular health checkup accompanied by her daughter to help translate CC I would like to establish care here in the US and to have someone manage my diabetes and cirrhosis. Developed by Camilla S. Graham, MD, BIDMC, 5/5/15. . cgraham@bidmc.harvard.edu. . . Slides can be selected or altered as needed.. Disclosures. 75% of People with Hepatitis C in the US are Baby Boomers. . HCV Training Workshop. Version 19.0. HCSP/HCV Advocate Staff. Alan . Franciscus. . –. . Executive Director, HCSP and Editor-in-Chief, HCV Advocate Website.. Clara . Maltrás.   – . an English to Spanish translator. Program in a Pharmacy Setting. Conveying . the Urgency of . HCV Testing. 1. How to Talk about Hepatitis C Testing. 2. Chronic HCV Infection May Lead to Chronic Liver Disease and Liver Cancer as well as Systemic Disease : DM, Renal Disease, Lymphoma and other problems . Liver Disease and Cirrhosis. Justin Mitchell, DO, MS. Assistant Professor. Rush University Medical Center. SGNA . 10/20/2018. No disclosures.. Objectives. Identify abnormal liver chemistries. . Recognize medications that may lead to harm in patient's with advanced liver disease. . . Case. 47-Year-Old . Man With Asymptomatic HIV Infection. Case (cont). Initial Clinical Presentation. Laboratory Results. HepaScore. ®. A Composite Biomarker Panel for Liver Fibrosis. Hepatic Steatosis in Patients With HIV/HCV Coinfection. IAPAC African Regional Capacity-Building Hub. Based in Johannesburg, South Africa. Mission: Strengthen clinician capacity to deliver HIV, HBV, and HCV treatment . Partners include:. . Supported through an educational grant from: . Medical Director, Austin Hepatitis Center. 1. Hepatitis C & PCP’s. 2. LACK OF AWARENESS. LACK OF APPROPRIATE ACTION. Expand Quantitative Landscape Study – Oct 2013 [Gilead Sciences]. 35-50% of PCP believe HCV can be cured. . FMC. Disclosures. nil. Learning objectives/. t. alk plan. Epidemiology and natural history of HCV infection in Australia. Who is at high risk for HCV and how to screen. How to evaluate patient with HCV. National Guidelines for Diagnosis & Management of Viral Hepatitis National Guidelines for PrefaceViral hepatitis is increasingly being recognized as a public health problem in India. While hepatitis A Nowlan Selvapatt. Consultant Hepatologist. Imperial College Healthcare NHS Trust . Overview. Understanding the scale of the problem. Brief overview of referral pathways. Diagnostics in Primary Care. of hepatitis C virus (HCV. ) infection; . a cohort study of women infected . postpartum. . with . contaminated . anti-D . immunoglobulin in Ireland between 1977 and . 1979. Patricia . Garvey, . EPIET fellow. Hansen Dang,. 1,2*. Yee Hui Yeo,. 1*. Satoshi Yasuda,. 3. Chung-Feng Huang,. 4. Etsuko Iio,. 5. Charles Landis,. 6. Dae Won Jun,. 7. Masaru Enomoto,. 8. Eiichi Ogawa,. 9. Pei-. Chien. Tsai,. & . Update on HCV . blood bank protocol. . Overview - . diagnostic tests. Serologic . assays: . specific antibody to hepatitis C virus (anti-HCV). Molecular . assays: HCV nucleic acid . (. nucleic. ASTRAL-4. Source: Curry MP, et al. N Engl J Med. 2015;373:2618-28.. Treatment Naïve and Treatment Experienced, Phase 3. Sofosbuvir-Velpatasvir in Decompensated HCV Cirrhosis. ASTRAL-4: Study Features.